Figure S4 from IL2/IL15 Signaling Induces NK Cell Production of FLT3LG, Augmenting Anti–PD-1 Immunotherapy

2026 Open access

Read full text
Authors: Shayan C. Avanessian, Renske J.E. van den Bijgaart, Nayvin W. Chew, Valentina M. Supper, Thao T. Tang, Yuzheng Zhang, Ying‐Qi Zhao, Kokoro Abe, Jordan Gauthier, Kevin C. Barry
DOI: 10.1158/2326-6066.31024160
Cited by: 0

Abstract

IL-2-treated NK cells augment ICB responses while IL-18-treated NK cells do not.

Fields of Study & Subjects

Immune Cell Function and Interaction Pediatric health and respiratory diseases IL-33 ST2 and ILC Pathways

Publication details

Publication date
8 January 2026